FDA approves blood typing tests

Jan 14, 2008

The U.S. Food and Drug Administration has licensed 14 new tests for determining a person's blood type.

"These 14 new tests will provide blood establishments and transfusion services with additional choices to help assure safe, well-matched transfusions," said Dr. Jesse Goodman, director of the FDA's Center for Biologics Evaluation and Research. "The tests offer a broader diversity of reliable blood-typing tests and will help protect against product shortages."

Knowing the blood types for blood donors and patients is critical since patients might experience serious life-threatening reactions from mismatched transfused blood.

The OLYMPUS PK System Blood Group and Phenotyping Reagents use monoclonal antibodies to test for the A, B, O, and Rh factors, as well as for other factors that signify a rarer blood type, the FDA said.

The tests are manufactured by DIAGAST of Loos Cedex, France.

Copyright 2008 by United Press International

Explore further: FDA approves second vaccine against meningitis strain

add to favorites email to friend print save as pdf

Related Stories

How malaria-spreading mosquitoes can tell you're home

12 minutes ago

Females of the malaria-spreading mosquito tend to obtain their blood meals within human dwellings. Indeed, this mosquito, Anopheles gambiae, spends much of its adult life indoors where it is constantly expose ...

A first peek beneath the surface of a comet

42 minutes ago

In some of the first research findings to be published from the European Space Agency's Rosetta Mission to the comet 67P/Churyumov-Gerasimenko, scientists including astronomer Peter Schloerb of the University ...

Recommended for you

Medical charity warns India over patent rules

Jan 21, 2015

Doctors without Borders on Wednesday warned the Indian government not to bow to US pressure to amend patent regulations that allow millions access to affordable medicines, ahead of a visit by President Barack Obama.

Why are some generic drugs getting so expensive?

Jan 21, 2015

More than eight out of every 10 prescriptions dispensed in the US is generic. This growth is due to a large number of top-selling drugs going off patent over the past decade, as well as innovations in t ...

Supreme Court sides with Teva in drug dispute

Jan 20, 2015

The Supreme Court on Tuesday sided with Teva Pharmaceutical Industries Ltd. in the company's high-profile patent dispute with rival firms over the top-selling multiple sclerosis drug.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.